| Record ID | ia:antimicrobialdru0000will |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/antimicrobialdru0000will/antimicrobialdru0000will_marc.xml |
| Download MARC binary | https://www.archive.org/download/antimicrobialdru0000will/antimicrobialdru0000will_meta.mrc |
LEADER: 03021cam 2200649 a 4500
001 ocm35016857
003 OCoLC
005 20200507043306.0
008 960722s1996 enka b 001 0 eng
040 $aUKM$beng$cUKM$dMIA$dUBA$dBAKER$dOCLCG$dYDXCP$dOCLNG$dAU@$dUAB$dZWZ$dDEBBG$dBDX$dOCLCF$dP4I$dKIJ$dOCLCO$dOCLCQ$dTFW$dGZH$dOCLCO$dUWO$dOCLCO$dOCLCA$dUKBTH
015 $aGB9647863$2bnb
019 $a846705395$a1027341761
020 $a1872748813$q(pbk.)
020 $a9781872748818$q(pbk.)
035 $a(OCoLC)35016857$z(OCoLC)846705395$z(OCoLC)1027341761
050 4 $aRM267$b.W544 1996
080 $a615.33
082 04 $a616.90461$220
084 $aVS 8700$2rvk
084 $aCHE 875f$2stub
096 $aQV 350$bW726a 1996
100 1 $aWilliams, R. A. D.$q(Ralph Anthony David),$d1938-
245 10 $aAntimicrobial drug action /$cR.A.D. Williams, P.A. Lambert, P. Singleton.
260 $aOxford :$bBIOS Scientific,$c1996.
300 $axi, 146 pages :$billustrations (some color) ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aMedical perspectives series
504 $aIncludes bibliographical references (pages 139-140) and index.
505 0 $a1. Chemotherapy of microbial infections / R.A.D. Williams -- 2. The antimetabolites: folate metabolism as a target for antimicrobial drugs / R.A.D. Williams -- 3. The cell wall as a target for antimicrobial drugs / R.A.D. Williams -- 4. Synthesis of nucleic acids as a target for antimicrobial drugs / R.A.D. Williams -- 5. Protein synthesis as a target for antibiotics / R.A.D. Williams -- 6. Membrane-active drugs effective against bacteria and fungi / P.A. Lambert -- 7. Chemotherapy of protozoal diseases / P. Singleton.
650 0 $aAntibiotics.
650 0 $aAnti-infective agents$xSide effects.
650 0 $aDrugs$xSide effects.
650 2 $aAnti-Infective Agents$xadverse effects.
650 2 $aAnti-Infective Agents$xdrug therapy.
650 2 $aAnti-Bacterial Agents.
650 7 $aAnti-infective agents$xSide effects.$2fast$0(OCoLC)fst00810348
650 7 $aAntibiotics.$2fast$0(OCoLC)fst00810420
650 7 $aDrugs$xSide effects.$2fast$0(OCoLC)fst00898912
650 7 $aAnti-infectieux$xPharmacologie.$2fmesh
650 7 $aAntibacte riens$xPharmacologie.$2fmesh
650 7 $aAntibioticos (ciencias farmaceuticas)$2larpcal
650 7 $aDrogas.$2larpcal
653 0 $aHumans$aCommunicable diseases$aDrug therapy
830 0 $aMedical perspectives series.
938 $aBaker & Taylor$bBKTY$c45.95$d45.95$i1872748813$n0002434343$sactive
938 $aBrodart$bBROD$n49505033$c$45.95
938 $aTaylor & Francis$bTYFR$n1872748813
938 $aYBP Library Services$bYANK$n1227569
029 1 $aAU@$b000011552736
029 1 $aDEBBG$bBV012262713
029 1 $aNLGGC$b149793553
029 1 $aNZ1$b4686705
029 1 $aZWZ$b025827715
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 91 OTHER HOLDINGS